ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,384, issued on Jan. 27, was assigned to Jiangnan University (Wuxi, China).
"Lactobacillus reuteri CCFM1132 capable of relieving hyperuricemia and application thereof" was invented by Gang Wang (Wuxi, China), Caixin Ni (Wuxi, China), Yuxing Zheng (Wuxi, China), Linlin Wang (Wuxi, China), Jianxin Zhao (Wuxi, China), Hao Zhang (Wuxi, China) and Wei Chen (Wuxi, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure discloses Lactobacillus reuteri CCFM1132 capable of relieving hyperuricemia and application thereof, which belongs to the technical field of microorganisms. The L. reuteri CCFM1132 can reduce serum uric acid levels of mic...